menu search

Immunic gets notice of allowance for us patent protecting treatment of relapsing ms with vidofludimus and salts

Immunic Inc (NASDAQ:IMUX) told investors it has received a Notice of Allowance from the US Patent and Trademark Office for a patent application protec...

November 2, 2023, 8:13 am

Immunic presents data from phase 2 study of vidofludimus calcium in relapsing-remitting ms

Immunic Inc (NASDAQ:IMUX) announced that data from its Phase 2 EMPhASIS trial of nuclear receptor-related 1 (Nurr1) activator, vidofludimus ...

October 11, 2023, 10:11 am

India calcium phosphite market size is expected to hit us$ 215.1 million by 2030 | capacity analysis, industry assessment and market study for 2023-2030 by rationalstat

India calcium phosphite market is expected to approach US$ 215.1 million by 2030, with an annual growth...

October 11, 2023, 8:37 am

Bridgebio pharma announces new england journal of medicine publication of positive encaleret proof-of-concept phase 2b results in patients with autosomal dominant hypocalcemia type 1 (adh1)

– In our study, encaleret restored physiologic mineral homeostasis in 13 participants with ADH1, specifically correcting hypocalcemia and reducing h...

October 10, 2023, 11:30 am

Immunic completes enrollment in trial of vidofludimus calcium in patients with progressive ms

Immunic Inc (NASDAQ:IMUX) said it has completed the enrollment of its phase 2 CALLIPER trial of lead asset vidofludimus ...

August 17, 2023, 8:19 am

Immunic reports 2q results; expects to be able to fund operations into 4q 2024

Immunic, Inc. said that at the end of its second quarter to June 30, 2023, it had cash, cash equivalents and investments of $77.3 million with which...

August 3, 2023, 9:18 am

Immunic has a blockbuster clinical pipeline to treat multiple sclerosis and gastrointestinal diseases

New York-based biotechnology company Immunic Inc (NASDAQ:IMUX) has one or more potential blockbusters in its clinical pipeline. The firm's promising l...

June 16, 2023, 8:01 am

Immunic to participate in scientific and investor conferences in june

NEW YORK , May 30, 2023 /PRNewswire/ -- Immunic, Inc.  (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered,...

May 30, 2023, 6:30 am

calcium channel blockers market predicted to reach $24 billion by 2031, propelled by 5.7% cagr – tmr study

Increase in the prevalence of cardiovascular diseases, a surge in geriatric population, and rise in the availability of combination therapies are driv...

May 29, 2023, 6:00 pm

Aluminosilicate market to reach a revenue of around us$ 298.5 million by the end of 2033: persistence market research

Consumption of calcium Aluminosilicate to Remain Highest among All Other Types New York, May 29, 2023 (...

May 29, 2023, 1:05 pm

Immunic notes neuroprotective potential of vidofludimus calcium highlighted in preclinical data

Immunic Inc (NASDAQ:IMUX) has announced the publication of preclinical data highlighting the neuroprotective potential of its investigational drug, v...

May 17, 2023, 8:21 am

calcium peroxide market size to reach usd 3.02 billion by 2032, at a rate of 3.6% between 2023 and 2032 – report by market research future (mrfr)

calcium Peroxide Market Research Report Information By Grade (Food and Industrial), By Application (Cla...

May 11, 2023, 8:30 am

calcium carbonate market is expected to reach usd 51,568.6 million by 2030, with a cagr of 4.24% – report by market research future (mrfr)

calcium Carbonate Market Research Report Information By Fusion Type (Anterior Interbody Fusion, Anterio...

April 28, 2023, 8:15 am

Bentonite market to soar at a rate of 4.12% between 2022 and 2030, from usd 1.49 billion in 2022 to usd 2.05 billion in 2030 – report by market research future (mrfr)

Bentonite Market Research Report Information By Product (Sodium Bentonite, calcium, Bentonite, Sulphur ...

April 27, 2023, 12:45 pm

Why shockwave medical stock blasted more than 10% higher on friday

A well-known peer is apparently interested in acquiring the medical device maker. Shockwave produces and sells products that use sound to break up ...

April 21, 2023, 4:45 pm

Immunic's (imux) ulcerative colitis study shows positive data

Immunic (IMUX) reports positive results from the maintenance phase of the phase II study evaluating its lead candidate, vidofludimus ...

April 6, 2023, 3:14 pm

Immunic's positive trial data for imu-838 impresses analysts

Immunic has caught the attention of market analysts with the release of positive data from the maintenance phase of its Phase 2b CALDOSE-1 trial of le...

April 6, 2023, 1:16 pm

Why is immunic (imux) stock up 23% today?

Immunic (NASDAQ: IMUX ) stock is getting a boost on Wednesday after the company released results from its Phase 2 CALDOSE-1 Trial. This study had it t...

April 5, 2023, 8:27 am

Immunic reports positive data from maintenance phase of phase 2 caldose-1 trial

Immunic Inc (NASDAQ:IMUX) has announced positive data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus ...

April 5, 2023, 7:36 am

Praxis: shaking the dust off calcium channel blockers for essential tremor

Praxis Precision Medicines' ulixacaltamide (PRAX-944) is a potent and selective small molecule T-type Ca2+ channel blocker being developed for the pot...

March 3, 2023, 2:26 am


Search within

Pages Search Results: